SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-023447
Filing Date
2020-04-03
Accepted
2020-04-03 18:45:46
Documents
2
Period of Report
2020-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3618
2 POA DOCUMENT poa.txt EX-24.3_908991 3652
  Complete submission text file 0001209191-20-023447.txt   8636
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Issuer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O APPLIED THERAPEUTICS, INC. 545 5TH AVENUE SUITE 1400 NEW YORK NY 10017
Business Address
Mahadevan Chids (Reporting) CIK: 0001808486 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38898 | Film No.: 20775330